The inductor of interferonogenesis amiksin in reducing of liver fibrosis and Hepatic Stellate Cell activation

被引：0
|
作者：
Abdulchakov, S
Sozinov, A
Kiassov, A
机构：
[1] Kazan Med Univ, Dept Therapy, Kazan, Russia
[2] Kazan Med Univ, Dept Infect Dis, Kazan, Russia
[3] Kazan Med Univ, Dept Anat, Kazan, Russia
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80225-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
226
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [21] Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis
    Ogawa, Hiroyuki
    Kaji, Kosuke
    Nishimura, Norihisa
    Takagi, Hirotetsu
    Ishida, Koji
    Takaya, Hiroaki
    Kawaratani, Hideto
    Moriya, Kei
    Namisaki, Tadashi
    Akahane, Takemi
    Yoshiji, Hitoshi
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (08) : 4001 - 4013
  • [22] KUPFFER CELL-HEPATIC STELLATE CELL CROSSTALK PROMOTES NF-κB ACTIVATION, HEPATIC STELLATE CELL SURVIVAL AND LIVER FIBROSIS
    Kluwe, Johannes
    De Minicis, Samuele
    Gwak, Geum-Youn
    Jean-Philippe, Pradere
    Jang, Myoung-Kuk
    Chava, Sreedivya
    Schwabe, Robert
    HEPATOLOGY, 2010, 52 (04) : 378A - 378A
  • [23] Role of PDLIM1 in hepatic stellate cell activation and liver fibrosis progression
    Bingyu Ye
    Mengli Yu
    Meijuan Yue
    Man Yin
    Chunyan Zhang
    Qiwen Wang
    Xinru Ding
    Wenlong Shen
    Zhihu Zhao
    Scientific Reports, 13
  • [24] Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability
    Xiao-Mei Yang
    Zheng Wu
    Xiaoqi Wang
    Yaoqi Zhou
    Lei Zhu
    Dongxue Li
    Hui-Zhen Nie
    Ya-Hui Wang
    Jun Li
    Xueyun Ma
    BMC Pharmacology and Toxicology, 23
  • [25] The role of Fyn in hepatic stellate cells activation and liver fibrosis
    Lu, Yin Ying
    Rong, Guanghua
    Feng, Dechun
    Wang, Chunping
    Chang, Xiujuan
    Gao, Xudong
    Chen, Yan
    Qu, Jianhui
    Zeng, Zhen
    Wang, Hong
    Gao, Bin
    Yang, Yongping
    HEPATOLOGY, 2014, 60 : 566A - 566A
  • [26] Osteopontin exacerbates activation of hepatic stellate cells and liver fibrosis
    Chen, J.
    Cui, G.
    Zhang, X.
    Diao, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 119 - 120
  • [27] Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis
    Dmitry Victorovich Garbuzenko
    World Journal of Clinical Cases, 2022, (12) : 3662 - 3676
  • [28] Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis
    Baghaei, Kaveh
    Mazhari, Sogol
    Tokhanbigli, Samaneh
    Parsamanesh, Gilda
    Alavifard, Helia
    Schaafsma, Dedmer
    Ghavami, Saeid
    DRUG DISCOVERY TODAY, 2022, 27 (04) : 1044 - 1061
  • [29] MICRORNA-155 PROMOTES HEPATIC STELLATE CELL ACTIVATION AND THE DEVELOPMENT OF LIVER FIBROSIS
    Zhuang, Yuan
    Bala, Shashi
    Zivny, Adam
    Wang, Yanbo
    Xie, Jun
    Gao, Guangping
    Szabo, Gyongyi
    HEPATOLOGY, 2022, 76 : S438 - S438
  • [30] Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis
    Du, Xiao-Sa
    Li, Hai-Di
    Yang, Xiao-Juan
    Li, Juan-Juan
    Xu, Jie-Jie
    Chen, Yu
    Xu, Qing-Qing
    Yang, Lei
    He, Chang-Sheng
    Huang, Cheng
    Meng, Xiao-Ming
    Li, Jun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 75
12345